This management's discussion and analysis should be read in conjunction with the
consolidated financial statements and notes included elsewhere in this Quarterly
Report on Form 10-Q. All amounts described in this section are in thousands,
except percentages, periods of time, and share and per share data.



This management's discussion and analysis, as well as other sections of this
Quarterly Report on Form 10-Q, may contain "forward-looking statements" that
involve risks and uncertainties, including statements regarding our plans,
future events, objectives, expectations, estimates, forecasts, assumptions, or
projections. Any statement that is not a statement of historical fact is a
forward-looking statement, and in some cases, words such as "believe,"
"estimate," "project," "expect," "intend," "may," "anticipate," "plan," "seek,"
and similar words or expressions identify forward-looking statements. These
statements involve risks and uncertainties that could cause actual outcomes and
results to differ materially from the anticipated outcomes or results, and undue
reliance should not be placed on these statements. These risks and uncertainties
include, but are not limited to, the matters discussed in Part II herein, under
the heading "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the
fiscal year ended December 31, 2021 and other risks and uncertainties discussed
in other filings made with the Securities and Exchange Commission (including
risks described in subsequent reports on Form 10-Q and Form 8-K and other
filings). We disclaim any intention or obligation, other than as required by
applicable law, to update or revise any forward-looking statements, whether as a
result of new information, future events, or otherwise.



Overview



We are a materials technology company that develops and commercializes products
made from amorphous alloys. Our Liquidmetal® family of alloys consists of a
variety of proprietary bulk alloys and composites that utilize the advantages
offered by amorphous alloy technology. We design, develop, and sell custom
products and parts from bulk amorphous alloys to customers in various
industries. We also partner with third-party manufacturers and licensees to
develop and commercialize Liquidmetal alloy products.



Amorphous alloys are, in general, unique materials that are distinguished by
their ability to retain a random atomic structure when they solidify, in
contrast to the crystalline atomic structure that forms in other metals and
alloys when they solidify. Liquidmetal alloys are proprietary amorphous alloys
that possess a combination of performance, processing, and potential cost
advantages that we believe will make them preferable to other materials in a
variety of applications. The amorphous atomic structure of bulk alloys enables
them to overcome certain performance limitations caused by inherent weaknesses
in crystalline atomic structures, thus facilitating performance and processing
characteristics superior in many ways to those of their crystalline
counterparts. We believe the alloys and the molding technologies we employ can
result in components for many applications that exhibit exceptional dimensional
control and repeatability that rivals precision machining, excellent corrosion
resistance, brilliant surface finish, high strength, high hardness, high elastic
limit, alloys that are non-magnetic, and the ability to form complex shapes
common to the injection molding of plastics. All of these characteristics are
achievable from the molding process, so design engineers often do not have to
select specific alloys to achieve one or more of the characteristics as is the
case with crystalline materials. We believe these advantages could result in
Liquidmetal alloys supplanting high-performance alloys, such as titanium and
stainless steel, and other incumbent materials in a wide variety of
applications. Moreover, we believe these advantages could enable the
introduction of entirely new products and applications that are not possible or
commercially viable with other materials.



Licensing Transactions



Eontec License Agreement



On March 10, 2016, we entered into a Parallel License Agreement (the "License
Agreement") with DongGuan Eontec Co., Ltd., a Hong Kong corporation ("Eontec")
pursuant to which the parties agreed to cross-license certain patents, technical
information, and trademarks between us and Eontec. In particular, we granted to
Eontec a paid-up, royalty-free, perpetual license to our patents and related
technical information to make, have made, use, offer to sell, sell, export, and
import products in certain geographic areas outside of North America and Europe,
and Eontec granted to us a paid-up, royalty-free, perpetual license to Eontec's
patents and related technical information to make, have made, use, offer to
sell, sell, export, and import products in certain geographic areas outside of
specified countries in Asia. The license granted by us to Eontec is exclusive
(including to the exclusion of us) in the countries of Brunei, Cambodia, China
(P.R.C and R.O.C.), East Timor, Indonesia, Japan, Laos, Malaysia, Myanmar,
Philippines, Singapore, South Korea, Thailand, and Vietnam. The license granted
by Eontec to us is exclusive (including to the exclusion of Eontec) in North
America and Europe. The cross-licenses are non-exclusive in geographic areas
outside of the foregoing exclusive territories.



                                       18

--------------------------------------------------------------------------------

Table of Contents

Beyond the License Agreement, we collaborate with Eontec to accelerate the commercialization of amorphous alloy technology. This includes but is not limited to developing technologies to reduce the cost of amorphous alloys, working on die cast machine technology platforms to pursue broader markets, sharing knowledge to broaden our intellectual property portfolio, and utilizing Eontec's volume production capabilities as a third party contract manufacturer.

Eutectix Business Development Agreement





On January 31, 2020, we entered into a Business Development Agreement (the
"Agreement") with Eutectix, LLC, a Delaware limited liability company
("Eutectix"), which provides for collaboration, joint development efforts, and
the manufacturing of products based on our proprietary amorphous metal alloys.
Under the Agreement, we have agreed to license to Eutectix specified equipment
owned by us, including two injection molding machines, the Machines, and other
machines and equipment, all of which will be used to make products for our
customers and Eutectix customers. The licensed machines and equipment represent
substantially all of the machinery and equipment currently held by us. We have
also licensed to Eutectix various patents and technical information related to
our proprietary technology. Under the Agreement, Eutectix will pay us a royalty
of six percent (6%) of the net sales price of licensed products sold by
Eutectix, and Eutectix will also manufacture products for us. The Agreement has
a term of five years, subject to renewal provisions and the ability of either
party to terminate earlier upon specified circumstances.



Apple License Transaction



On August 5, 2010, we entered into a license transaction with Apple pursuant to
which (i) we contributed substantially all of our intellectual property assets
to a newly organized special-purpose, wholly-owned subsidiary, called Crucible
Intellectual Property, LLC ("CIP"), (ii) CIP granted to Apple a perpetual,
worldwide, fully-paid, exclusive license to commercialize such intellectual
property in the field of consumer electronic products, as defined in the license
agreement, in exchange for a license fee, and (iii) CIP granted back to us a
perpetual, worldwide, fully-paid, exclusive license to commercialize such
intellectual property in all other fields of use.



Under the agreements relating to the license transaction with Apple, we were
obligated to contribute, to CIP, all intellectual property developed by us
through February 2016. We are also obligated to maintain certain limited
liability company formalities with respect to CIP at all times after the closing
of the license transaction.


Other Material License Transactions





On January 13, 2022, our majority owned subsidiary, Liquidmetal Golf ("LMG"),
entered into a sublicense agreement ("LMG Sublicense Agreement") with Amorphous
Technologies Japan, Inc. ("ATJ"), a newly formed Japanese entity that was
established by Twins Corporation, a sporting goods company operating in Japan.
Under the agreement, LMG granted to ATJ a nonexclusive worldwide sublicense to
our amorphous alloy technology and related trademarks to manufacture and sell
golf clubs and golf related products. The LMG Sublicense Agreement has a term of
three years and provides for the payment of a running royalty to LMG of 3% of
the net sales price of licensed products.



In March 2009, we entered into a license agreement with Swatch Group, Ltd.
("Swatch") under which Swatch was granted a non-exclusive license to our
technology to produce and market watches and certain other luxury products. In
March 2011, this license agreement was amended to grant Swatch exclusive rights
as to watches and all third parties (including us), but non-exclusive as to
Apple. We will receive royalty payments over the life of the contract on all
Liquidmetal products produced and sold by Swatch. The license agreement with
Swatch will expire on the expiration date of the last licensed patent.



Critical Accounting Policies and Estimates





The preparation of consolidated financial statements in conformity with
accounting principles generally accepted in the United States requires us to
make estimates and assumptions that affect reported amounts of assets and
liabilities and disclosure of contingent assets and liabilities at the date of
the financial statements and the reported amounts of revenues and expenses
during the reporting period. These estimates and assumptions are based on
historical experience and various other factors that are believed to be
reasonable under the circumstances. Actual results could differ materially from
these estimates under different assumptions or conditions.



                                       19

--------------------------------------------------------------------------------

Table of Contents





We believe that the following accounting policies are the most critical to our
consolidated financial statements since these policies require significant
judgment or involve complex estimates that are important to the portrayal of our
financial condition and operating results:



  • Revenue recognition
  • Impairment of long-lived assets and definite-lived intangibles
  • Deferred tax assets
  • Share based compensation




Our Annual Report on Form 10-K for the year ended December 31, 2021 (the "2021
Annual Report") contains further discussions on our critical accounting policies
and estimates.





Results of Operations


Comparison of the three and nine months ended September 30, 2022 and 2021





                            For the three months ended September 30,                     For the nine months ended September 30,
                      2022                             2021                         2022                            2021
                                       % of                          % of                            % of                         % of
                    in 000's         Revenue         in 000's       Revenue       in 000's          Revenue       in 000's       Revenue


Revenue:
Products            $      18                        $     406                   $       284                      $     700
Licensing and
royalties                   -                                -                            22                             21
Total revenue              18                              406                           306                            721

Cost of sales              15            83%               319         79%               243           79%              528         73%
Gross profit                3            17%                87         21%                63           21%              193         27%

Selling,
marketing,
general and
administrative            744           4133%            1,643         405%            2,319           758%           3,372         468%
Research and
development                19           106%                14          3%                46           15%               74         10%
Total operating
expense                   763                            1,657                         2,365                          3,446

Operating loss           (760 )                         (1,570 )                      (2,302 )                       (3,253 )

Lease income              133                              132                           398                            396
Interest and
investment income          56                               35                            51                            138
Net loss            $    (571 )                      $  (1,403 )                 $    (1,853 )                    $  (2,719 )

Revenue and operating expenses





Revenue. Total revenue decreased to $18 for the three months ended September 30,
2022 from $406 for the three months ended September 30, 2021. Total revenue
decreased to $306 for the nine months ended September 30, 2022 from $721 for the
nine months ended September 30, 2021. The decrease for both period was
attributable to lower general production shipments of products made by our
contract manufacturers and decreases in payments under development projects,
following the Company's transition to outsourced manufacturing in 2020.



Cost of sales. Cost of sales was $15, or 83% of total revenue, for the three
months ended September 30, 2022, a decrease from $319, or 79% of total revenue,
for the three months ended September 30, 2021. Cost of sales was $243, or 79% of
total revenue, for the nine months ended September 30, 2022, an increase from
$528, or 73% of total revenue, for the nine months ended September 30, 2021. The
decrease for the three months ended September 30, 2022 and 2021 was attributable
to lower products revenue, increase in licensing and royalties revenue, and
lower gross profit percentages. The decrease for the nine months ended September
30, 2022 and 2021 was attributable to lower products revenue, decrease in
licensing and royalties revenue, and higher gross profit percentages. If we
begin increasing our products revenues with shipments of routine, commercial
products and parts through third party contract manufacturers, we expect our
cost of sales percentages to decrease, stabilize and be more predictable.



Gross profit. Our gross profit decreased to $3 for the three months ended
September 30, 2022 from $87 for the three months ended September 30, 2021. Our
gross profit as a percentage of total revenue, decreased to 17% for the three
months ended September 30, 2022 from 21% for the three months ended September
30, 2021. Our gross profit decreased to $63 for the nine months ended September
30, 2022 from $193 for the nine months ended September 30, 2021. Our gross
profit as a percentage of total revenue, decreased to 21% for the nine months
ended September 30, 2022 from 27% for the nine months ended September 30, 2021.
Early prototype and pre-production orders generally result in a higher cost mix,
relative to revenue, than would otherwise be incurred in an on-site production
environment, with higher volumes and more established operating processes, or
through contract manufacturers. As such, our gross profit percentages have
fluctuated and may continue to fluctuate based on volume and quoted production
prices per unit and may not be representative of our future business. If we
begin increasing our products revenues with shipments of routine, commercial
products and parts through future orders to third party contract manufacturers,
we expect our gross profit percentages to stabilize, increase, and be more
predictable.



                                       20

--------------------------------------------------------------------------------

Table of Contents





Selling, marketing, general and administrative. Selling, marketing, general, and
administrative expenses were $744 and $2,319 for the three and nine months ended
September 30, 2022, respectively, compared to $1,657 and $3,446 for the three
and nine months ended September 30, 2021, respectively. The decrease in expenses
was primarily attributable to lower stock-based compensation as well as
continued cost reductions.



Research and development. Research and development expenses were $19 and $46 for
the three and nine months ended September 30, 2022, respectively, compared to
$14 and $74 for the three and nine months ended September 30, 2021,
respectively. We continue to perform research and development of new Liquidmetal
alloys and related processing capabilities, albeit on a reduced basis in
comparison with prior periods.



Operating loss. Operating loss was $760 and $2,302 for the three and nine months
ended September 30, 2022, respectively. This compares to $1,570 and $3,253 for
the three and nine months ended September 30, 2021, respectively. Fluctuations
in our operating loss are primarily attributable to variations in operating
expenses, as discussed above.



We continue to invest in our technology infrastructure to expedite the adoption
of our technology, but we have experienced long sales lead times for customer
adoption of our technology. Until that time when we can either (i) increase our
revenues with shipments of routine, commercial products and parts through third
party contract manufacturers or (ii) obtain significant licensing revenues, we
expect to continue to have operating losses for the foreseeable future.



Other income and expenses



Lease income. Lease income relates to straight-line rental income received under
the Facility Lease. Such amounts were $133 and $398 for the three and nine
months ended September 30, 2022, respectively. This compares to $132 and $396
for the three and nine months ended September 30, 2021, respectively.



Interest and investment income. Interest and investment income relates to
interest earned from our cash deposits and investments in debt securities for
the respective periods. Interest and investment was $56 and $51 for the three
and nine months ended September 30, 2022, respectively. This compares to
interest and investment income of $35 and $138 during the three and nine months
ended September 30, 2021, respectively. The decrease during 2022 is due
continued volatility in corporate debt and bond markets, which is resulting in
reduced yields.


Liquidity and Capital Resources

Cash used in operating activities





Cash used in operating activities totaled $1,452 and $1,635 for the nine months
ended September 30, 2022 and 2021, respectively. The cash was primarily used to
fund operating expenses related to our business and product development efforts.



Cash provided by investing activities





Cash provided by investing activities totaled $2,564 and provided by investing
activities totaled $5,354 for the nine months ended September 30, 2022 and 2021,
respectively. Investing inflows primarily consist of proceeds from the sale of
debt securities. Investing outflows primarily consist of purchases of debt
securities.



Cash provided by financing activities





Cash provided by financing activities totaled $212 for the nine months ended
September 30, 2022 related to the exercise of our stock options, and $0 for the
nine months ended September 30, 2021.



Financing arrangements and outlook





We have a relatively limited history of selling bulk amorphous alloy products
and components on a mass-production scale. Furthermore, the ability of future
contract manufacturers to produce our products in desired quantities and at
commercially reasonable prices is uncertain and is dependent on a variety of
factors that are outside of our control, including the nature and design of the
component, the customer's specifications, and required delivery timelines. These
factors have previously required that we engage in equity sales under various
stock purchase agreements to support its operations and strategic initiatives.



                                       21

--------------------------------------------------------------------------------

Table of Contents





However, as of September 30, 2022, we had $5,420 in cash and restricted cash, as
well as $19,208 in investments in debt securities. We view this total of $24,628
as readily available sources of liquidity in the event needed to advance our
existing strategy, and/or pursue an alternative strategy. As such, we anticipate
that our current capital resources, when considering expected losses from
operations, will be sufficient to fund our operations for the foreseeable
future.

© Edgar Online, source Glimpses